|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
Onyx Pharmaceuticals Acquires Proteolix, Carfilzomib [October 12, 2009]
Onyx Breast Cancer Trial Results [September 30, 2009]
Onyx Positive Surprise for Investors [November 11, 2008]
2009 |
|||
 |
|
|
|
02/23/2009 |
05/06/2009 |
08/04/2009 |
11/03/2009 |
Q4 2008 |
Q1 2009 |
Q2 2009 |
Q3 2009 |
2008 |
|||
|
|
|
|
11/06/2008 |
08/05/2008 |
05/06/2008 |
02/19/2008 |
Q3 2008 |
Q2 2008 |
Q1 2008 |
Q4 2007 |
2007 |
|||
|
|
|
|
11/06/2007 |
08/07/2007 |
05/09/2007 |
02/15/2007 |
Q3 2007 |
Q2 2007 |
Q1 2007 |
Q4 2006 |
2006 |
|||
|
|
|
|
11/07/2006 |
08/08/2006 |
05/05/2006 |
|
Q3 2006 |
Q2 2006 |
Q1 2006 |
|
Onyx Chooses the Long Run [August 11, 2008]
Onyx In The Black [May 7, 2008]
Onyx (ONXX) Nexavar Trial and Q4 results comments [February 20, 2008]
Can Onyx Deliver? [May 10, 2007]
First bought on May 9, 2008
Onyx Web site:
Onyx (ONXX) is a biotech or pharmaceutical company. Its primary product is Nexavar for kidney and liver cancer.
Disclaimer: Our analyst summaries may include both our condensations of statements made by company representatives and our own analysis. They are not covered by any warranty. We cannot guarantee anything said by company representatives is true. Before making or terminating an investment you should always verify any factual basis of your decision.